Portfolio
Recent News
Funded projects
 |
|
 |
John Rowlands, XLV Diagnostics Inc. Project: X-ray light valve for mammography This low-cost system offer the potential for expanding women’s access to digital mammography. |
|
|
 |
Aaron Wheeler, University of Toronto Project: A Digital Microfluidic Platform for High-Throughput Apoptosis Screening (Smart Well-PlateTM) This standard 96 well-sized plate is compatible with existing equipment and has no moving parts for cost-effective phenotypic screening of human cells against chemical libraries to accelerate drug discovery. |
|
|
 |
Khaled El Emam, Privacy Analytics Inc. Project: Methods for de-identification of geospatial data and longitudinal medical records This software platform, called Privacy Analytics Risk Assessment Tool (PARAT), unlocks the vast potential of data on diseases and patient care without compromising individual privacy. |
|
|
 |
John Valliant, McMaster University Project: Development of Radiolabeled Insulin Probe A form of insulin labelled with technetium that is injected into the bloodstream and used to track changes in insulin metabolism, helping to find and monitor tumours. |
|
|
 |
Kullervo Hynynen, Sunnybrook Health Sciences Centre Project: Low-cost Focused Ultrasound System A system using ultrasound to both detect and treat tumours in bone and liver for the relief of pain without surgery and without expensive imaging equipment. |
|
|
 |
Joseph Elliot, OncoTek Drug Delivery Inc. Project: Preclinical Development of PoLi-PTX, Intraperitoneal Ovarian Cancer Therapy A biocompatible and biodegradable gel that provides sustained release of/images drug at the site of surgery with fewer side effects than traditional chemotherapy. |
|
|
 |
Shana Kelley & Ted Sargent, University of Toronto Project: Validation of the GenEplex Platform for Clinically Accepted Leukemia Biomarkers An inexpensive, sensitive, multiplex chip that detects DNA, RNA or protein targets directly without amplification steps. |
|
|
|
Jorge Filmus, Sunnybrook Health Sciences Centre Project: Glypican-3: A Novel Marker for the Early Diagnosis of Hepatocellular Carcinoma A highly specific blood test to detect early liver cancer in individuals at risk. |
|
|
 |
Aaron Schimmer, University Health Network Project: Development of Novel Chemical Proteasome Inhibitors A small molecule active against blood cancers including those resistant to Velcade®. |
|
|
|
Gang Zheng, University Health Network Project: Nanoparticles for Targeted Delivery of siRNA-Based Cancer Therapeutics A small particle that mimics “good” cholesterol and delivers therapeutic siRNA directly to the cytoplasm of cells. |
|
|
|
Michael Sherar, University Health Network Project: Novel Radio Frequency Ablation Technology for Treatment of Solid Tumours A coiled device inserted through a needle uses novel physics to treat large tumours in the liver, kidney and lung. |
|
|
 |
DVS Sciences Inc. Project: Flow Cytometer-Mass Spectrometer for Multi-Parametric Biomarker Analysis A unique analytical instrument for high throughput and highly multiplexed analyses of biomarkers for research, clinical trials and personalized medicine. University of Toronto chemistry technology promises more effective prescription drug therapies The Soul Of A Cell: Stanford Researchers Use Advanced Instrument To Read Cells’ Minds |
|
|
 |
Aaron Fenster, Robarts Research Institute Project: 3D Ultrasound-Guided Prostate Biopsy and Therapy A device and software that uses 3D ultrasound for highly accurate biopsy and treatment of prostate tumours even in large glands. |
|
|
|
Li Zhang, University Health Network Project: Novel Cellular Immunotherapy for Cancer A special type of rare blood cell is grown outside the body then re-infused into the patient to treat acute myeloid leukemia (AML). |
|
|
| |
Michael Bronskill & Rajiv Chopra, Sunnybrook Health Sciences Centre Project: Real-Time MRI-Guided Ultrasound Therapy Prostate Cancer A rapid, highly accurate and minimally invasive therapy to treat prostate cancer via the urethra with fewer medical complications than other approaches. Toronto medical device company closes C$9.4M in Series A venture capital financing |
|
|
 |
Project: Colon Cancer Genetic Risk Prediction Tool A genetic test that provides information regarding an individual’s genetic risk of sporadic colorectal cancer to guide screening decisions. |
|
|